Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.
about
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to HypoxiaSunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic AgentHypoxia-shaped vascular niche for cancer stem cellsDose-dependent effects of allopurinol on human foreskin fibroblast cells and human umbilical vein endothelial cells under hypoxiaThe Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis.The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer.Spheroid-plug model as a tool to study tumor development, angiogenesis, and heterogeneity in vivo.Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.Sunitinib Treatment Enhances Metastasis of Innately Drug-Resistant Breast Tumors.Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.In vivo biocompatibility assessment of poly (ether imide) electrospun scaffolds.Immune consequences of anti-angiogenic therapyin renal cell carcinoma.Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumabExosome-related tumor microenvironment
P2860
Q28085029-680CCCA0-6CAE-483D-B460-3A0B67073447Q30313895-CFC1C777-441D-4FD8-A5B2-EA6A5F75C53FQ33744134-6623F6A1-606F-4AC4-B95B-1CFD53B8ACB5Q35066326-3146EFDC-ACF0-47BF-AF11-DC399361BCC7Q35592005-33CEE9E8-C0A2-42D4-98A8-C4A42F66A3B2Q36300487-7C1FE006-B3CB-4A0E-BB95-F67D1A85BA33Q36420167-3CEABC00-3061-40A5-91CB-D5093B26B4C3Q36828773-134C7814-B34F-49BA-A895-B5EBA9F885C1Q37209499-AC815233-9CED-48CE-8904-C05651EC0EDDQ37660355-C95A3AF2-4757-45F2-A520-B085415691F3Q38968841-61D9472C-4C2C-40EA-B954-83AC94468226Q52869368-4558B7CF-B22B-49D2-B8CF-323E330EFCE4Q54981236-3940E61F-ECAE-46F5-ADDD-35C524221A76Q58130125-9F4497B8-2DEB-4C56-92E2-83A984BE08D9Q58798356-936EAFDE-B66C-46EF-91FE-4D8F39BD5ADC
P2860
Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypoxia-regulated overexpressi ...... sis and inhibits tumor growth.
@en
Hypoxia-regulated overexpressi ...... sis and inhibits tumor growth.
@nl
type
label
Hypoxia-regulated overexpressi ...... sis and inhibits tumor growth.
@en
Hypoxia-regulated overexpressi ...... sis and inhibits tumor growth.
@nl
prefLabel
Hypoxia-regulated overexpressi ...... sis and inhibits tumor growth.
@en
Hypoxia-regulated overexpressi ...... sis and inhibits tumor growth.
@nl
P2093
P2860
P50
P1476
Hypoxia-regulated overexpressi ...... sis and inhibits tumor growth.
@en
P2093
Alexandra Foucault-Collet
Bouchra El Hafny-Rahbi
Claudine Kieda
Jacek Stepniewski
Jozef Dulak
Krzysztof Klimkiewicz
Nathalie Lamerant-Fayel
P2860
P304
P356
10.1158/1535-7163.MCT-13-0637
P50
P577
2013-10-29T00:00:00Z